Effects of Renin-Angiotensin System Blockers on Renal Outcomes and All-cause Mortality in Patients With Diabetic Nephropathy: An Updated Meta-analysis | Zendy

Pantelis Sarafidis | Zendy; Panagiotis Stafylas | Zendy; Angeliki Kanaki | Zendy; Anastasios N. Lasaridis | Zendy

Open Access

Effects of Renin-Angiotensin System Blockers on Renal Outcomes and All-cause Mortality in Patients With Diabetic Nephropathy: An Updated Meta-analysis

Author(s) -

Pantelis Sarafidis,

Panagiotis Stafylas,

Angeliki Kanaki,

Anastasios N. Lasaridis

Publication year - 2008

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1038/ajh.2008.206

Subject(s) - medicine , renin–angiotensin system , angiotensin receptor blockers , diabetic nephropathy , nephropathy , angiotensin converting enzyme , diabetes mellitus , cardiology , endocrinology , blood pressure , kidney

In contrast to previous studies, recent data questioned the ability of renin-angiotensin-aldosterone system (RAAS) blockers to delay progression of diabetic nephropathy. This study evaluated the effect of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in patients with diabetic nephropathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research